Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Neoplasms 2Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Oligodendroglioma 1Metastatic Castration-resistant Prostate Cancer 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Gliosarcoma 1Glioma 1Glioblastoma 1Carcinoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

cabazitaxel 1XRP6258 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphadenopathy × cabazitaxel × Clear all
NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
170 enrolled 22 charts
Genitourinary

Lymphadenopathy, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡